GET MORE FROM MEDICINES.
RxAnte delivers analytics-powered solutions and clinical services that enable health plans, care providers, and pharmaceutical manufacturers to realize more value from medicines.
-
Our mission is to improve how medicines are prescribed, taken, and paid for. We do things like:
Help health plans improve Medicare Part D and HEDIS quality measures and avoid medical costs related to medication non-adherence.
Enable care providers to better understand and address barriers to their patients’ medication use.
Inform meaningful, evidence-driven discussions with pharmaceutical manufacturers and health plans about drug performance and contracting.
-
The no-obligation RxAnte Adherence Strategy Report is how top-performing Part D plans design their adherence programs.
Highly accurate performance forecasting. Know where you’ll land on the triple-weighted measures this year.
Program simulations. Learn how many interventions are needed to achieve your adherence goals.
Strategic advisory services. Our experts guide your program strategy.
-
Stars Tool: 2019 CMS Stars Data Now Available
Our interactive tool for health plans has been updated. See Star Ratings comparisons across medication measures and the correlation between them. Filters, sliders, and hover capabilities let you see what you need to succeed against rising cut points.
The Results
Below are a few ways we measure medication performance improvement for our clients:
of Medicare Part D contract measures managed by RxAnte improve year-over-year
in annual savings opportunities identified for a health plan deploying our medical cost savings solution.
adherence improvement among plan members reached using our RxEffect® medication adherence workflow solution.
For Health Plans
Deploy our analytics-powered solutions to improve clinical quality, achieve medical cost savings, and better realize the value of medicines on your member populations.
Tell Me More
For Providers
Drive improvements in shared risk arrangements using our predictive analytics and direct-to-patient interventions to ensure patients’ adherence to their medicines.
Tell Me MoreFor Pharmaceutical Manufacturers
Demonstrate the value of drugs on real-world populations and engage in value-based contracts using our evidence-driven approach and transparent performance measurement analytics.
Tell Me More
Resources & Blog
More Resources
Assessing the Value of Predictive Analytics for MAPD Plans
Blog Post
There’s a grossly unaddressed problem in the industry for Medicare Advantage Part D (MAPD) plans. That problem is the ambiguous role of “predictive analytics.” Well today, we’re throwing down the gauntlet and questioning the purpose and value of predictive analytics.
RxAnte Announces Partnership with Geisinger Health Plan to Drive Pharmacy Quality Strategy and Outcomes
Press Release
How MAPD Plans Can Achieve Successful Product Implementation
Blog Post
This week, our Vice President of Product Strategy and Management, gives Medicare Advantage Part D (MAPD) plans the low down on product implementation. Read on to get her tips on what to watch out for – and what to ask for – to ensure success with health tech partners as you gear up for new ways to beat cut points in 2019 and beyond.
Request More Info
Think RxAnte might be right for your organization? Let’s get in touch.
Let's Get StartedUpcoming Events
More Resources
Medicare Star Ratings and Quality Assurance Summit (Dec. 4-5, 2018)
Event
RxAnte will be attending the 4th Annual Medicare Star Ratings and Quality Assurance Summit, December 4-5, 2018. Kerri Petrin, VP of Client Services will host a case study session on Day One, featuring RxAnte's medication adherence workflow solution, RxEffect.
RISE Star Ratings Master Class (Dec. 11-12, 2018)
Event
RxAnte is attending the RISE Star Ratings Master Class, December 11-12, 2018. We’ll be available to discuss the latest in medication adherence solutions to help health plans looking to reduce costs and optimize their adherence strategies to achieve their operational and Star Ratings goals.